World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
109
Citations
50567
World Ranking
5719
National Ranking
3074

Richard L. Wahl publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Richard L. Wahl sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 733 publications — 83rd percentile

83% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Richard L. Wahl D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Richard L. Wahl sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 109 D-Index — 72nd percentile

72% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2015 - Member of the National Academy of Medicine (NAM)
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Richard L. Wahl is affiliated with Washington University in St. Louis in the United States. Their research is predominantly situated within the field of Medicine, with significant contributions to subfields such as Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine, Oncology, Cancer Research, and Epidemiology.

The scientist has contributed extensively to various research topics. These include:

  • Medical Imaging Techniques and Applications
  • Radiomics and Machine Learning in Medical Imaging
  • Radiopharmaceutical Chemistry and Applications
  • Prostate Cancer Treatment and Research
  • HER2/EGFR in Cancer Research
  • Neuroendocrine Tumor Research Advances
  • Neuroblastoma Research and Treatments

Among their recent scholarly articles are the following publications:

  • Joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards on recommended use of [18F]FDG PET/CT imaging during immunomodulatory treatments in patients with solid tumors version 1.0, 2022, European Journal of Nuclear Medicine and Molecular Imaging
  • Nuclear Medicine and Artificial Intelligence: Best Practices for Evaluation (the RELAINCE Guidelines), 2022, Journal of Nuclear Medicine
  • Radiotherapy and theranostics: a Lancet Oncology Commission, 2024, The Lancet Oncology
  • Nuclear Medicine and Artificial Intelligence: Best Practices for Algorithm Development, 2021, Journal of Nuclear Medicine
  • The QIBA Profile for FDG PET/CT as an Imaging Biomarker Measuring Response to Cancer Therapy, 2020, Radiology

The scientist's frequent collaborators include:

  • Lilja B. Sólnes
  • Abhinav K. Jha
  • Farrokh Dehdashti
  • Roisín M. Connolly
  • Vered Stearns

Richard L. Wahl's work has been published extensively in a number of venues, including:

  • Journal of Nuclear Medicine (31 publications)
  • Journal of Clinical Oncology (6 publications)
  • European Journal of Nuclear Medicine and Molecular Imaging (5 publications)
  • arXiv (Cornell University) (5 publications)
  • Tomography (3 publications)

Recognition of their contributions includes election as a Member of the National Academy of Medicine in 2015 and membership in the Association of American Physicians.

Best Publications

  • From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors

    Richard L. Wahl;Heather Jacene;Yvette Kasamon;Martin A. Lodge

  • American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer

    Gary H. Lyman;Armando E. Giuliano;Mark R. Somerfield;Al B. Benson

  • Recommendations on the Use of 18F-FDG PET in Oncology

    James W. Fletcher;James W. Fletcher;Benjamin Djulbegovic;Heloisa P. Soares;Barry A. Siegel

  • Pitfalls in Oncologic Diagnosis with FDG PET Imaging: Physiologic and Benign Variants

    Paul D. Shreve;Yoshimi Anzai;Richard L. Wahl

  • Metastases from non-small cell lung cancer: mediastinal staging in the 1990s--meta-analytic comparison of PET and CT.

    Ben A. Dwamena;Seema S. Sonnad;Jeff O. Angobaldo;Richard L. Wahl

  • 131I-tositumomab therapy as initial treatment for follicular lymphoma.

    Mark S. Kaminski;Melissa Tuck;Judith Estes;Arne Kolstad

  • Radioimmunotherapy of B-Cell Lymphoma with [131I]Anti-B1 (Anti-CD20) Antibody

    Mark S. Kaminski;Kenneth R. Zasadny;Isaac R. Francis;Adam W. Milik

  • Radioimmunotherapy with iodine 131I tositumomab for relapsed or refractory B-cell non-Hodgkin lymphoma: Updated results and long-term follow-up of the University of Michigan experience

    Mark S. Kaminski;Judith Estes;Kenneth R. Zasadny;Isaac R. Francis

  • Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: Variations with body weight and a method for correction

    Kenneth R. Zasadny;Richard L. Wahl

  • Dynamic Imaging of Allogeneic Mesenchymal Stem Cells Trafficking to Myocardial Infarction

    Dara L. Kraitchman;Mitsuaki Tatsumi;Wesley D. Gilson;Takayoshi Ishimori

  • Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation.

    Richard L. Wahl;Ken Zasadny;Mark Helvie;Gary D. Hutchins

  • Pivotal study of iodine I 131 tositumomab for chemotherapy-refractory low-grade or transformed low-grade B-cell non-Hodgkin's lymphomas

    M. S. Kaminski;A. D. Zelenetz;O. W. Press;M. Saleh

  • Demonstration of accuracy and clinical versatility of mutual information for automatic multimodality image fusion using affine and thin-plate spline warped geometric deformations.

    Charles R. Meyer;Jennifer L. Boes;Boklye Kim;Peyton H. Bland

  • Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation.

    Richard L. Wahl;Leslie E. Quint;Robert L. Greenough;Charles R. Meyer

  • Primary and metastatic breast carcinoma: initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose.

    Richard L. Wahl;Robert L. Cody;Gary D. Hutchins;Elizabeth E. Mudgett

  • Iodine-131-anti-B1 radioimmunotherapy for B-cell lymphoma.

    M. S. Kaminski;K. R. Zasadny;I. R. Francis;M. C. Fenner

  • Uptake in Supraclavicular Area Fat (“USA-Fat”): Description on 18F-FDG PET/CT

    Christian Cohade;Medhat Osman;Harpreet K. Pannu;Richard L. Wahl

  • Does FDG Uptake Measure Proliferative Activity of Human Cancer Cells? In Vitro Comparison with DNA Flow Cytometry and Tritiated Thymidine Uptake

    Kotaro Higashi;Anaira C. Clavo;Richard L. Wahl

  • Iodine Biokinetics and Dosimetry in Radioiodine Therapy of Thyroid Cancer: Procedures and Results of a Prospective International Controlled Study of Ablation After rhTSH or Hormone Withdrawal

    Heribert Hänscheid;Michael Lassmann;Markus Luster;Stephen R. Thomas

  • Multicenter phase II study of iodine-131 tositumomab for chemotherapy- relapsed/refractory low-grade and transformed low-grade B-cell non-Hodgkin's lymphomas

    Julie Marie Vose;Richard L. Wahl;Mansoor Saleh;Ama Z. Rohatiner

Frequent Co-Authors

George Sgouros
George Sgouros Johns Hopkins University
Eric C. Frey
Eric C. Frey Johns Hopkins University
Arman Rahmim
Arman Rahmim University of British Columbia
Frank M. Bengel
Frank M. Bengel Hannover Medical School
Martin G. Pomper
Martin G. Pomper Johns Hopkins University School of Medicine
Benjamin M. W. Tsui
Benjamin M. W. Tsui Johns Hopkins University
Elliot K. Fishman
Elliot K. Fishman Johns Hopkins University
Isaac R. Francis
Isaac R. Francis University of Michigan–Ann Arbor
Vered Stearns
Vered Stearns Johns Hopkins University
Paul E. Kinahan
Paul E. Kinahan University of Washington

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a medical career in the USA often means exploring different education and certification options. Online degrees provide greater flexibility, allowing you to fast-track your studies or specialize in areas with high demand. For nurses aiming to reach the highest clinical practice level quickly, a 1 year dnp program online allows rapid progression to leadership roles in healthcare settings.

If you are searching for less rigorous advanced nursing pathways, explore easiest dnp programs to find options that balance comprehensive learning with an approachable workload. For those at the start of their career in nursing, a 9 month lpn program presents a fast, accessible entry point into the healthcare workforce.

Specializing further, mental health professionals can choose the shortest online pmhnp programs to quickly gain credentials in psychiatric and mental health nursing. With so many online options, there are flexible, streamlined pathways to diverse medical careers in the USA.

Best Scientists Citing Richard L. Wahl

Trending Scientists